AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
iwAL 2022 Session III: novel targets, combinations and treatment strategies in AML
VJHemOnc Podcast
Exploring Primary Endpoints for TP53 Mutant Patients in AML
This chapter questions the importance of using complete remission rate (CR) as the primary endpoint for TP53 mutant patients in AML studies and suggests that overall survival (OS) may be a more relevant endpoint. Previous studies that showed an increase in CR rate but no benefit in OS are mentioned, and the need to explore early predictors such as VAF clearance is suggested.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode